NCT00928200: Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) |
|
|
| Terminated | 1 | 1 | US | Erwinase, Asparaginase, Elspar, Kidrolase, L-Asparaginase, Erwinia L-Asparaginase, Vincristine, Oncovin, Vincasar Pfs, Vincristine Sulfate, LCR, VCR, Dexamethasone, Decadron, Dexasone, Diodex, Hexadrol, Maxidex, Dexamethasone sodium phosphate, Dexamethasone acetate, Doxorubicin, Adriamycin, Rubex, Cytarabine, Cytosar-U, Ara-C, Arabinosylcytosine, Methotrexate, Otrexup, Rasuvo, Rheumatrex, Trexall, Amethopterin, Methotrexate Sodium, MTX, Triple Intrathecal Therapy, Dexrazoxane, Zinecard | Therapeutic Advances in Childhood Leukemia Consortium | Relapsed Acute Lymphoblastic Leukemia, Allergy to PEG e.Coli Asparaginase, Allergy to Native e.Coli Asparaginase | 06/10 | 06/10 | | |
